Cargando…

Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study

Data about the characteristics and prevalence of complementary medicine (CM) product use by Australians, including concurrent use with prescription and over-the-counter medications, have not been collected in the last five years. A cross-sectional online survey involving a representative sample of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Harnett, Joanna, McIntyre, Erica, Adams, Jon, Addison, Tamia, Bannerman, Holly, Egelton, Lucy, Ma, Jessica, Zabakly, Leon, Steel, Amie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860983/
https://www.ncbi.nlm.nih.gov/pubmed/36678198
http://dx.doi.org/10.3390/nu15020327
_version_ 1784874727695712256
author Harnett, Joanna
McIntyre, Erica
Adams, Jon
Addison, Tamia
Bannerman, Holly
Egelton, Lucy
Ma, Jessica
Zabakly, Leon
Steel, Amie
author_facet Harnett, Joanna
McIntyre, Erica
Adams, Jon
Addison, Tamia
Bannerman, Holly
Egelton, Lucy
Ma, Jessica
Zabakly, Leon
Steel, Amie
author_sort Harnett, Joanna
collection PubMed
description Data about the characteristics and prevalence of complementary medicine (CM) product use by Australians, including concurrent use with prescription and over-the-counter medications, have not been collected in the last five years. A cross-sectional online survey involving a representative sample of the Australian population was administered in 2021–2022. Of the 2351 survey responses included in this study, 49.4% reported use of a CM product over the previous 12-month period. Of these, 50% reported they always or often used CM products on the same day as a prescription medicine. Participants aged 65 and over were five times more likely to use CMs and other medications on the same day compared to 18–24-year-olds. Lower levels of education and having a chronic illness were also predictors of same-day use. The prevalence and characteristics of CM use by participants was similar to data collected five years ago. The study shows that concurrent use of CM products with prescription medications among older and more vulnerable populations is prevalent and this area requires further research to help ensure appropriate and safe use of CM products.
format Online
Article
Text
id pubmed-9860983
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98609832023-01-22 Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study Harnett, Joanna McIntyre, Erica Adams, Jon Addison, Tamia Bannerman, Holly Egelton, Lucy Ma, Jessica Zabakly, Leon Steel, Amie Nutrients Article Data about the characteristics and prevalence of complementary medicine (CM) product use by Australians, including concurrent use with prescription and over-the-counter medications, have not been collected in the last five years. A cross-sectional online survey involving a representative sample of the Australian population was administered in 2021–2022. Of the 2351 survey responses included in this study, 49.4% reported use of a CM product over the previous 12-month period. Of these, 50% reported they always or often used CM products on the same day as a prescription medicine. Participants aged 65 and over were five times more likely to use CMs and other medications on the same day compared to 18–24-year-olds. Lower levels of education and having a chronic illness were also predictors of same-day use. The prevalence and characteristics of CM use by participants was similar to data collected five years ago. The study shows that concurrent use of CM products with prescription medications among older and more vulnerable populations is prevalent and this area requires further research to help ensure appropriate and safe use of CM products. MDPI 2023-01-09 /pmc/articles/PMC9860983/ /pubmed/36678198 http://dx.doi.org/10.3390/nu15020327 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Harnett, Joanna
McIntyre, Erica
Adams, Jon
Addison, Tamia
Bannerman, Holly
Egelton, Lucy
Ma, Jessica
Zabakly, Leon
Steel, Amie
Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title_full Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title_fullStr Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title_full_unstemmed Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title_short Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
title_sort prevalence and characteristics of australians complementary medicine product use, and concurrent use with prescription and over-the-counter medications—a cross sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860983/
https://www.ncbi.nlm.nih.gov/pubmed/36678198
http://dx.doi.org/10.3390/nu15020327
work_keys_str_mv AT harnettjoanna prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT mcintyreerica prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT adamsjon prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT addisontamia prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT bannermanholly prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT egeltonlucy prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT majessica prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT zabaklyleon prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy
AT steelamie prevalenceandcharacteristicsofaustralianscomplementarymedicineproductuseandconcurrentusewithprescriptionandoverthecountermedicationsacrosssectionalstudy